Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 5
1996 8
1997 4
1998 7
1999 6
2000 4
2001 3
2002 1
2003 5
2004 3
2005 3
2007 3
2008 6
2009 2
2010 1
2011 1
2012 4
2013 2
2014 2
2015 4
2016 2
2017 3
2018 3
2019 4
2020 5
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Gender and funding success.
Appel-Cresswell S, Blanchet PJ, Wysocki J, Postuma RB. Appel-Cresswell S, et al. Among authors: blanchet pj. Lancet. 2019 Jun 1;393(10187):2195-2196. doi: 10.1016/S0140-6736(19)31107-9. Lancet. 2019. PMID: 31162073 No abstract available.
Antipsychotic drug-induced movement disorders.
Blanchet PJ. Blanchet PJ. Can J Neurol Sci. 2003 Mar;30 Suppl 1:S101-7. doi: 10.1017/s0317167100003309. Can J Neurol Sci. 2003. PMID: 12691483 Review.
Pathophysiology of L-dopa-induced dyskinesias.
Bédard PJ, Blanchet PJ, Lévesque D, Soghomonian JJ, Grondin R, Morissette M, Goulet M, Calon F, Falardeau P, Gomez-Mancilla B, Doucet JP, Robertson GS, DiPaolo T. Bédard PJ, et al. Among authors: blanchet pj. Mov Disord. 1999;14 Suppl 1:4-8. Mov Disord. 1999. PMID: 10493397 Review. No abstract available.
Chronic pain and pain processing in Parkinson's disease.
Blanchet PJ, Brefel-Courbon C. Blanchet PJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):200-206. doi: 10.1016/j.pnpbp.2017.10.010. Epub 2017 Oct 12. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 29031913 Review.
A Focused Update on Tardive Dyskinesia.
Blanchet PJ. Blanchet PJ. Can J Neurol Sci. 2020 Nov;47(6):747-755. doi: 10.1017/cjn.2020.131. Epub 2020 Jul 6. Can J Neurol Sci. 2020. PMID: 32624027
Relevance of animal models to human tardive dyskinesia.
Blanchet PJ, Parent MT, Rompré PH, Lévesque D. Blanchet PJ, et al. Behav Brain Funct. 2012 Mar 9;8:12. doi: 10.1186/1744-9081-8-12. Behav Brain Funct. 2012. PMID: 22404856 Free PMC article. Review.
New and emerging treatments for symptomatic tardive dyskinesia.
Rana AQ, Chaudry ZM, Blanchet PJ. Rana AQ, et al. Among authors: blanchet pj. Drug Des Devel Ther. 2013 Nov 6;7:1329-40. doi: 10.2147/DDDT.S32328. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24235816 Free PMC article. Review.
Oral dyskinesia: a clinical overview.
Blanchet PJ, Rompré PH, Lavigne GJ, Lamarche C. Blanchet PJ, et al. Int J Prosthodont. 2005 Jan-Feb;18(1):10-9. Int J Prosthodont. 2005. PMID: 15754887 Review.
Molecular basis of levodopa-induced dyskinesias.
Calon F, Grondin R, Morissette M, Goulet M, Blanchet PJ, Di Paolo T, Bédard PJ. Calon F, et al. Among authors: blanchet pj. Ann Neurol. 2000 Apr;47(4 Suppl 1):S70-8. Ann Neurol. 2000. PMID: 10762134 Review.
Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms.
Blanchet PJ, Calon F, Morissette M, Hadj Tahar A, Bélanger N, Samadi P, Grondin R, Grégoire L, Meltzer L, Di Paolo T, Bédard PJ. Blanchet PJ, et al. Parkinsonism Relat Disord. 2004 Jul;10(5):297-304. doi: 10.1016/j.parkreldis.2004.02.011. Parkinsonism Relat Disord. 2004. PMID: 15196509 Review.
87 results